urapidil has been researched along with Coronary Artery Disease in 1 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fractional flow reserve (FFR, calculated by coronary pressure measurements during adenosine-induced hyperaemia) was assessed in 85 patients with an intermediate coronary stenosis (mean diameter stenosis of 50+/-1%) and normal left ventricular function which were divided into the following three groups: (a) 33 patients before and after IC bolus of phentolamine, an alpha1-, alpha2-adrenergic blocker; (b) 32 patients before and after IC bolus of urapidil, a selective alpha1-adrenergic blocker; (c) 20 patients before and after IC bolus of saline." | 3.72 | Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. ( Aarnoudse, W; Barbato, E; Bartunek, J; De Bruyne, B; Heyndrickx, GR; Pijls, NH; Staelens, F; Vanderheyden, M; Wijns, W, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbato, E | 1 |
| Bartunek, J | 1 |
| Aarnoudse, W | 1 |
| Vanderheyden, M | 1 |
| Staelens, F | 1 |
| Wijns, W | 1 |
| Heyndrickx, GR | 1 |
| Pijls, NH | 1 |
| De Bruyne, B | 1 |
1 other study available for urapidil and Coronary Artery Disease
| Article | Year |
|---|---|
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Coronar | 2004 |